Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

  • Anette Gabriele Ziegler
  • , Peter Achenbach
  • , Reinhard Berner
  • , Kristina Casteels
  • , Thomas Danne
  • , Melanie Gündert
  • , Joerg Hasford
  • , Verena Sophia Hoffmann
  • , Olga Kordonouri
  • , Karin Lange
  • , Helena Elding Larsson
  • , Markus Lundgren
  • , Matthew D. Snape
  • , Agnieszka Szypowska
  • , John A. Todd
  • , Ezio Bonifacio

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry